Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '7-HYDROXYSTAUROSPORINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Smith, JA; Cortes, J; Newman, RA; Madden, TL
      Development of a simplified, sensitive high-performance liquid chromatographic method using fluorescence detection to determine the concentration of UCN-01 in human plasma

      JOURNAL OF CHROMATOGRAPHY B
    2. Harvey, S; Decker, R; Dal, Y; Schaefer, G; Tang, L; Kramer, L; Dent, P; Grant, S
      Interactions between 2-fluoroadenine 9-beta-d-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells

      CLINICAL CANCER RESEARCH
    3. Redkar, AA; Meadows, GG; Daoud, SS
      UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice

      INTERNATIONAL JOURNAL OF ONCOLOGY
    4. Graves, PR; Lovly, CM; Uy, GL; Piwnica-Worms, H
      Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding

      ONCOGENE
    5. Abe, S; Kubota, T; Otani, Y; Furukawa, T; Watanabe, M; Kumai, K; Akiyama, T; Akinaga, S; Kitajima, M
      UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery

      JAPANESE JOURNAL OF CANCER RESEARCH
    6. Senderowicz, AM
      Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies

      LEUKEMIA
    7. Sausville, EA; Arbuck, SG; Messmann, R; Headlee, D; Bauer, KS; Lush, RM; Murgo, A; Figg, WD; Lahusen, T; Jaken, S; Jing, XX; Roberge, M; Fuse, E; Kuwabara, T; Senderowicz, AM
      Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms

      JOURNAL OF CLINICAL ONCOLOGY
    8. Cholody, WM; Kosakowska-Cholody, T; Michejda, CJ
      Bisimidazoacridones induce a potent cytostatic effect in colon tumor cellsthat sensitizes them to killing by UCN-01

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. Yasoshima, K; Kuwabara, T; Fuse, E; Kuramitu, T; Kurata, N; Nishiie, H; Oishi, T; Kobayashi, H; Kobayashi, S
      Pharmacokinetics, distribution, metabolism and excretion of [H-3]UCN-01 inrats and dogs after intravenous administration

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    10. Hu, BC; Zhou, XY; Wang, X; Zeng, ZC; Iliakis, G; Wang, Y
      The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Hirose, Y; Berger, MS; Pieper, RO
      p53 effects both the duration of G(2)/M arrest and the fate of temozolomide-treated human glioblastoma cells

      CANCER RESEARCH
    12. Hirose, Y; Berger, MS; Pieper, RO
      Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells

      CANCER RESEARCH
    13. Dai, Y; Yu, CR; Singh, V; Tang, L; Wang, ZL; McInistry, R; Dent, P; Grant, S
      Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells

      CANCER RESEARCH
    14. Gescher, A
      Staurosporine analogues - pharmacological toys or useful antitumour agents?

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    15. Senderowicz, AM
      Small molecule modulators of cyclin-dependent kinases for cancer therapy

      ONCOGENE
    16. Monks, A; Harris, ED; Vaigro-Wolff, A; Hose, CD; Connelly, JW; Sausville, EA
      UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines

      INVESTIGATIONAL NEW DRUGS
    17. Akiyama, T; Sugiyama, K; Shimizu, M; Tamaoki, T; Akinaga, S
      G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation

      JAPANESE JOURNAL OF CANCER RESEARCH
    18. Kurata, N; Kuwabara, T; Tanii, H; Fuse, E; Akiyama, T; Akinaga, S; Kobayashi, H; Yamaguchi, K; Kobayashi, S
      Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor,UCN-01

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    19. Kruger, EA; Blagosklonny, MV; Dixon, SC; Figg, WD
      UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response

      INVASION & METASTASIS
    20. Eastman, A; Rigas, JR
      Modulation of apoptosis signaling pathways and cell cycle regulation

      SEMINARS IN ONCOLOGY
    21. Jiang, H; Yang, LY
      Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: Association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins

      CANCER RESEARCH
    22. SAUSVILLE EA; LUSH RD; HEADLEE D; SMITH AC; FIGG WD; ARBUCK SG; SENDEROWICZ AM; FUSE E; TANII H; KUWABARA T; KOBAYASHI S
      CLINICAL-PHARMACOLOGY OF UCN-01 - INITIAL OBSERVATIONS AND COMPARISONTO PRECLINICAL MODELS

      Cancer chemotherapy and pharmacology
    23. GESCHER A
      ANALOGS OF STAUROSPORINE - POTENTIAL ANTICANCER DRUGS

      General pharmacology
    24. TSUCHIDA E; URANO M
      THE EFFECT OF UCN-01 (7-HYDROXYSTAUROSPORINE), A POTENT INHIBITOR OF PROTEIN-KINASE-C, ON FRACTIONATED RADIOTHERAPY OR DAILY CHEMOTHERAPY OF A MURINE FIBROSARCOMA

      International journal of radiation oncology, biology, physics
    25. POLLACK IF; KAWECKI S; LAZO JS
      BLOCKING OF GLIOMA PROLIFERATION IN-VITRO AND IN-VIVO AND POTENTIATING THE EFFECTS OF BCNU AND CISPLATIN - UCN-01, A SELECTIVE PROTEIN-KINASE-C INHIBITOR

      Journal of neurosurgery
    26. HILL DL; TILLERY KF; ROSE LM; POSEY CF
      DISPOSITION IN MICE OF 7-HYDROXYSTAUROSPORINE, A PROTEIN-KINASE INHIBITOR WITH ANTITUMOR-ACTIVITY

      Cancer chemotherapy and pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 11:51:57